Results 301 to 310 of about 177,759 (314)

Insulin Resistance the Link between T2DM and CVD: Basic Mechanisms and Clinical Implications

Current Vascular Pharmacology, 2019
Amin Jayyousi, Ralph A Defronzo, Nidal Asaad   +2 more
exaly  

Gut Microbiota-Dependent Trimethylamine-N-oxide and Serum Biomarkers in Patients with T2DM and Advanced CKD

Journal of Clinical Medicine, 2017
Kameswara Rao Kottapalli, Tetyana L Vasylyeva   +1 more
exaly  

Sanhuang xiexin decoction synergizes insulin/PI3K-Akt/FoxO signaling pathway to inhibit hepatic glucose production and alleviate T2DM

Journal of Ethnopharmacology, 2023
exaly  

Effects of a 6-month multi-strain probiotics supplementation in endotoxemic, inflammatory and cardiometabolic status of T2DM patients: A randomized, double-blind, placebo-controlled trial

Clinical Nutrition, 2019
Shaun Sabico, Kaiser Wani, Osama E Amer
exaly  

Targeting gut microbiota as a therapeutic target in T2DM: A review of multi-target interactions of probiotics, prebiotics, postbiotics, and synbiotics with the intestinal barrier

Pharmacological Research
Zezheng Gao
exaly  

Vardenafil in men with T2DM

Nature Reviews Urology, 2016
openaire   +1 more source

Hospital readmission increases T2DM costs

PharmacoEconomics & Outcomes News, 2015
openaire   +1 more source

SLC16A11 variant associated with T2DM

Nature Reviews Endocrinology, 2015
openaire   +1 more source

Clinical research progress on β-cell dysfunction in T2DM development in the Chinese population

Reviews in Endocrine and Metabolic Disorders
Yibing Chen, Qian Jiang
exaly  

Atorvastatin cost effective in T2DM

PharmacoEconomics & Outcomes News, 2020
openaire   +1 more source